Popular Business News

Dr Reddy’s Arm Reports Positive Results from Phase 1 Study

Dr Reddy’s Arm Reports Positive Results from Phase 1 Study

Ribrecabtagene autoleucel is an autologous CAR-T therapy that uses a humanized single-domain antibody as its binding domain. The clinical trials for DRL-1801 ar...

  • 08 Oct2024
  • 2 Min Read

Take your investment to next level

Open a FREE* Demat and Trading account to invest in Stocks, Mutual Funds, IPOs and more

Latest Business News


Other News Categories